Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Halpin

Showing results (151-160 of 197) with videos related to

Pageof 20
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|December 4, 2020
A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPDSimon Wan Yau Ming, John Haughney, Dermot Ryan, et al.
Journal of Asthma and Allergy|July 5, 2022
Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma ExacerbationNicola A Hanania, Jorge F Maspero, David M G Halpin, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 14, 2019
The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countriesD M G Halpin, B R Celli, G J Criner, et al.
The European Respiratory Journal|July 6, 2019
It is time for the world to take COPD seriously: a statement from the GOLD board of directorsDavid M G Halpin, Bartolome R Celli, Gerard J Criner, et al.
American Journal of Respiratory and Critical Care Medicine|June 26, 2020
The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical TrialMeiLan K Han, Gerard J Criner, Mark T Dransfield, et al.
The Lancet. Respiratory Medicine|April 11, 2014
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohortRupert C M Jones, David Price, Dermot Ryan, et al.
Respiratory Research|April 29, 2021
InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbationsDave Singh, Gerard J Criner, Mark T Dransfield, et al.
Thorax|August 22, 2024
Consensus palliative care referral criteria for people with chronic obstructive pulmonary diseaseJennifer Philip, Yuchieh Kathryn Chang, Anna Collins, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 13, 2022
Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary DiseaseJill A Ohar, Gary T Ferguson, Donald A Mahler, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 10, 2022
Dupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid DoseChristian Domingo, Jorge F Maspero, Mario Castro, et al.
Pageof 20

Showing results (151-160 of 197) with videos related to

Sort By:
Pageof 20
International Journal of Chronic Obstructive Pulmonary Disease|December 4, 2020
A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPDSimon Wan Yau Ming, John Haughney, Dermot Ryan, et al.
Journal of Asthma and Allergy|July 5, 2022
Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma ExacerbationNicola A Hanania, Jorge F Maspero, David M G Halpin, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 14, 2019
The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countriesD M G Halpin, B R Celli, G J Criner, et al.
The European Respiratory Journal|July 6, 2019
It is time for the world to take COPD seriously: a statement from the GOLD board of directorsDavid M G Halpin, Bartolome R Celli, Gerard J Criner, et al.
American Journal of Respiratory and Critical Care Medicine|June 26, 2020
The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical TrialMeiLan K Han, Gerard J Criner, Mark T Dransfield, et al.
The Lancet. Respiratory Medicine|April 11, 2014
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohortRupert C M Jones, David Price, Dermot Ryan, et al.
Respiratory Research|April 29, 2021
InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbationsDave Singh, Gerard J Criner, Mark T Dransfield, et al.
Thorax|August 22, 2024
Consensus palliative care referral criteria for people with chronic obstructive pulmonary diseaseJennifer Philip, Yuchieh Kathryn Chang, Anna Collins, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 13, 2022
Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary DiseaseJill A Ohar, Gary T Ferguson, Donald A Mahler, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 10, 2022
Dupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid DoseChristian Domingo, Jorge F Maspero, Mario Castro, et al.
Pageof 20